Results 21 to 30 of about 17,864 (222)

Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance

open access: yesJournal of Intensive Care, 2020
Along with the recent spread of multidrug-resistant bacteria, outbreaks of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing bacteria present a serious challenge to clinicians.
Teiji Sawa   +2 more
doaj   +1 more source

Carbapenemase-producing Klebsiella pneumoniae [PDF]

open access: yesF1000Prime Reports, 2014
The continuing emergence of infections due to multidrug resistant bacteria is a serious public health problem. Klebsiella pneumoniae, which commonly acquires resistance encoded on mobile genetic elements, including ones that encode carbapenemases, is a prime example. K. pneumoniae carrying such genetic material, including both blaKPC and genes encoding
Robilotti, Elizabeth, Deresinski, Stan
openaire   +2 more sources

OXA-type carbapenemases in Acinetobacter baumannii in South America

open access: yesJournal of Infection in Developing Countries, 2011
Acinetobacter baumannii is an opportunistic pathogen that is frequently involved in outbreaks of infection, occurring mostly in intensive care units. The increasing incidence of carbapenem resistance in A.
Andrés Opazo   +4 more
doaj   +1 more source

Carbapenemases: the Versatile β-Lactamases [PDF]

open access: yesClinical Microbiology Reviews, 2007
SUMMARYCarbapenemases are β-lactamases with versatile hydrolytic capacities. They have the ability to hydrolyze penicillins, cephalosporins, monobactams, and carbapenems. Bacteria producing these β-lactamases may cause serious infections in which the carbapenemase activity renders many β-lactams ineffective.
Anne Marie, Queenan, Karen, Bush
openaire   +2 more sources

The epidemiology of carbapenemases in Latin America and the Caribbean [PDF]

open access: yes, 2020
Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. infections are major causes of morbidity and mortality, especially due to the emergence and spread of β-lactamases.
Reyes, Sergio   +3 more
core   +1 more source

Antimicrobial Resistance: Carbapenemases-producing bacteria in livestock [PDF]

open access: yes, 2016
Carbapenems are antibiotics authorised for the treatment of humans and categorised by the World Health Organisation as critically important antimicrobials. Antibiotics of this kind should only be administered when there are strict indications, i.e.
German Federal Institute for Risk Assessment (BfR)
core   +1 more source

Impact of Hospital Wastewater on the Occurrence and Diversity of Beta-Lactamase Genes During Wastewater Treatment with an Emphasis on Carbapenemase Genes: A Metagenomic Approach

open access: yesFrontiers in Environmental Science, 2021
The diversity of beta-lactam antibiotic resistance genes, with particular emphasis on carbapenemase genes, during the treatment process at two wastewater treatment plants (WWTPs) with different levels of hospital wastewater inflow was investigated using ...
Jakub Hubeny   +6 more
doaj   +1 more source

The “hidden” carbapenemase of Aeromonas hydrophila [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1996
It has been presumed that there are just two beta-lactamases in the motile Aeromonas species, a carbapenemase and a cephalosporinase, based on the premise that all beta-lactamases can be detected by hydrolysis of the chromogenic cephalosporin, nitrocefin.
M V, Hayes, C J, Thomson, S G, Amyes
openaire   +2 more sources

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

open access: yesFrontiers in Microbiology, 2022
ObjectivesCARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E.
Javier E. Cañada-García   +128 more
doaj   +1 more source

Rapid Detection of Carbapenemase and Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria Directly from Positive Blood Cultures Using a Novel Protocol

open access: yesAntibiotics, 2022
Background: Early and adequate antibiotic treatment is the cornerstone of improving clinical outcomes in patients with bloodstream infections (BSI).
Diego Fernando Josa   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy